668 related articles for article (PubMed ID: 26641631)
1. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
3. Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD.
Vedel-Krogh S; Nordestgaard BG; Lange P; Vestbo J; Nielsen SF
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29650563
[TBL] [Abstract][Full Text] [Related]
4. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
[TBL] [Abstract][Full Text] [Related]
5. High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.
Çolak Y; Afzal S; Lange P; Nordestgaard BG
Int J Epidemiol; 2016 Oct; 45(5):1551-1559. PubMed ID: 27118560
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
[TBL] [Abstract][Full Text] [Related]
8. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
[TBL] [Abstract][Full Text] [Related]
9. Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study.
Çolak Y; Afzal S; Nordestgaard BG; Lange P; Vestbo J
Am J Respir Crit Care Med; 2021 May; 203(10):1245-1256. PubMed ID: 33142077
[No Abstract] [Full Text] [Related]
10. Predicting exacerbations in COPD in the Danish general population.
Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Nordestgaard BG; Lange P
Respir Med; 2024 Apr; 224():107557. PubMed ID: 38355020
[TBL] [Abstract][Full Text] [Related]
11. A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils.
Marks-Konczalik J; Costa M; Robertson J; McKie E; Yang S; Pascoe S
Respir Med; 2015 Jul; 109(7):860-9. PubMed ID: 26033641
[TBL] [Abstract][Full Text] [Related]
12. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
[TBL] [Abstract][Full Text] [Related]
14. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
Melbye H; Al-Ani S; Spigt M
Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
[TBL] [Abstract][Full Text] [Related]
15. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of COPD depends on severity of exacerbation history: A population-based analysis.
Çolak Y; Afzal S; Marott JL; Nordestgaard BG; Vestbo J; Ingebrigtsen TS; Lange P
Respir Med; 2019 Aug; 155():141-147. PubMed ID: 31362177
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
[TBL] [Abstract][Full Text] [Related]
18. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
[TBL] [Abstract][Full Text] [Related]
19. Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
Çolak Y; Ingebrigtsen TS; Nordestgaard BG; Marott JL; Lange P; Vestbo J; Afzal S
Ann Allergy Asthma Immunol; 2022 Oct; 129(4):490-496. PubMed ID: 35835293
[TBL] [Abstract][Full Text] [Related]
20. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
